CATHERINE M OTTO
Osteopathic Medicine at Pacific St, Seattle, WA

License number
Washington MD00019797
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-4300
(206) 543-6420

Professional information

Catherine Otto Photo 1

Ultrasound Training And Testing System With Multi-Modality Transducer Tracking

US Patent:
2011030, Dec 15, 2011
Filed:
May 13, 2011
Appl. No.:
13/107632
Inventors:
Florence Sheehan - Mercer Island WA, US
Catherine M. Otto - Seattle WA, US
Edward L. Bolson - Redmond WA, US
Mark D. Anderson - Stanwood WA, US
Assignee:
higher education - Seattle WA
International Classification:
G09B 23/28
US Classification:
434267
Abstract:
An apparatus and a method reproduce a diagnostic or interventional procedure that is performed by medical personnel using ultrasound imaging. A simulator of ultrasound imaging is used for purposes such as training medical professionals, evaluating their competence in performing ultrasound-related procedures, and maintaining, refreshing, or updating those skills over time.


Catherine M Otto Photo 2

Catherine M Otto, Seattle WA

Specialties:
Cardiologist
Address:
University Of Washington Medical Ctr, Seattle, WA 98195
Education:
University of Washington, School of Medicine - Doctor of Medicine
University of Washington Medical Center - Fellowship - Cardiology
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)


Catherine Mary Otto Photo 3

Catherine Mary Otto, Seattle WA

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
University Of Washington Medical Ctr
1959 Ne Pacific St, Seattle, WA 98195
Education:
University of Washington (1979)


Catherine M Otto Photo 4

Dr. Catherine M Otto, Seattle WA - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
(206) 598-5637 (Phone), (206) 598-4303 (Fax)
Echo Lab-UW Medicine
1959 NE Pacific St STE SE300J, Seattle 98195
(206) 598-7000 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Tilt Testing or Cardiac Event Monitors
Conditions:
Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Dissection, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Coarctation of the Aorta, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Endocarditis, Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart Disease, Hypotension, Marfan Syndrome, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Septal Defect, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1985, Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
Echo Lab-UW Medicine
1959 NE Pacific St STE SE300J, Seattle 98195
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
University Of Washington School Of Medicine
Graduated: 1979
New York Presbyterian Hospital/Weill Cornell Med Center
Graduated: 1980
Graduated: 1982
University Of Washington
Graduated: 1985


Catherine Otto Photo 5

Methods Of Inhibition Of Stenosis And/Or Sclerosis Of The Aortic Valve

US Patent:
2004005, Mar 25, 2004
Filed:
Nov 24, 2003
Appl. No.:
10/398492
Inventors:
Kevin O'Brien - Seattle WA, US
Catherine Otto - Seattle WA, US
Jeffrey Probstfield - Kirkland WA, US
International Classification:
A61K048/00, A61K039/395, A61K031/401, A61K031/366
US Classification:
424/146100, 514/044000, 514/423000, 514/460000, 514/548000
Abstract:
The present invention provides methods for decreasing the amount and/or biological activity of angiotensin II in an aortic valve in an animal. The methods of the invention include administering to the animal an amount of an angiotensin converting enzyme antagonist and/or an angiotensin II type 1 receptor antagonist, effective to decrease the amount and/or biological activity of angiotensin II in the aortic valve in the animal.